TLRY
$6.68
Tilray
($.68)
(9.24%)
TLRY
Earnings Whisper ®
N/A
4th Quarter December 2020
Consensus:  ($0.14)
Revenue:  $56.42 Mil
Monday
Feb 8
4:05 PM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch
Latest EPS
Monday, November 9, 2020

What do you expect when TLRY reports earnings?
Beat
Meet
Miss

Where is TLRY's stock price going from here?
Up
Flat
Down
Stock chart of TLRY
Analysts
Summary of analysts' recommendations for TLRY
Score
Grade
Pivots
Resistance
$7.82
$7.59
$7.13

$6.90

Support
$6.44
$6.21
$5.75
Tweet
Growth
Description
Tilray, Inc. is a pharmaceutical company. It develops cannabis based medicines, drugs, drops and oil products. Tilray, Inc. is based in NANAIMO, Canada.